CIP Newsletter No 132
QUANTITATIVE IMAGING FOR EVALUATION OF RESPONSES TO CANCER THERAPIES (U01) (NCI) (PAR-11-150)
This NCI CIP FOA is designed to promote research on quantitative imaging of tumor response to cancer therapies in clinical trial settings, with the overall goal of facilitating clinical decision making. Proposed projects should include the appropriate development and adaptation/implementation of quantitative imaging methods, protocols and software solutions/tools (using existing commercial imaging platforms and instrumentation), and their application in current and planned Phase 1-2 clinical therapy trials. No support for the clinical trials, as such, will be provided under this FOA. See http://imaging.cancer.gov/programsandresources/SpecializedInitiatives/qin for more information.
NANOSCIENCE AND NANOTECHNOLOGY IN BIOLOGY AND MEDICINE (R01: PA-11-148) (R21: PA-11-149) (MULTIPLE ICS INCLUDING NCI) (PA-11-148)
Application due dates: standards dates apply
This initiative, issued by the National Institutes of Health, encourages applications from institutions/organizations that apply nanoscience and nanotechnology approaches to address problems in biology and medicine. NCI lists imaging devices, cancer theragnostics with improved imaging contrast capability and other ICs are interested in imaging research.
URL for R01: http://grants.nih.gov/grants/guide/pa-files/PA-11-148.html
URL for R21: http://grants.nih.gov/grants/guide/pa-files/PA-11-149.html
RUTH L. KIRSCHSTEIN NATIONAL RESEARCH SERVICE AWARD (NRSA) INSTITUTIONAL RESEARCH TRAINING GRANTS (PARENT T32) (MULTIPLE ICs, INCLUDING NCI) (PA-11-184)
Application due dates: standard dates apply
The objective of the T32 program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation. This program supports predoctoral and postdoctoral research training programs (including those with short term research training) at domestic institutions of higher education with the T32 funding mechanism.
RUTH L. KIRSCHSTEIN NATIONAL RESEARCH SERVICE AWARD SHORT-TERM INSTITUTIONAL RESEARCH TRAINING GRANTS (PARENT T35) (MULTIPLE ICs, NOT INCLUDING NCI) (PA-11-185)
Application due dates: standard dates apply
The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grants (T35) to eligible institutions to develop or enhance research training opportunities for predoctoral and postdoctoral level individuals interested in careers in biomedical, behavioral and clinical research.
NLM INSTITUTIONAL TRAINING GRANTS FOR RESEARCH TRAINING IN BIOMEDICAL INFORMATICS (T-15) (LM-11-001) (NLM)
Letter of intent: March 28, 2011 (Letters of intent are not mandatory)
Application due date: April 28, 2011
The National Library of Medicine (NLM) invites applications for support of pre-doctoral and post-doctoral training programs leading to research careers in biomedical informatics. Applications may be for the creation of entirely new training programs or for the renewal of existing NLM training program grants. Healthcare/clinical informatics includes imaging informatics.
Application due date: April 28, 2011
DIABETES RESEARCH CENTERS (P30)(NIDDK) (DK-11-002)
Letter of intent due: May 31, 2011
Application due date: June 30, 2011
This Funding Opportunity Announcement (FOA) invites new and renewal applications for Diabetes Research Centers, formerly named Diabetes Endocrinology Research Centers (DERCs) and Diabetes Research and Training Centers (DRTCs). Diabetes Research Centers are designed to support and enhance the national research effort in diabetes and related endocrine and metabolic diseases.
Examples of biomedical cores include imaging.
PARTNERSHIPS FOR BIODEFENSE (R01) (AI-11-014) (NIAID)
Letter of intent: April 27, 2011
Application due date: May 27, 2011
This FOA, issued by the NIAID, invites research applications for projects that support preclinical development of lead candidate vaccines, therapeutics, adjuvants or diagnostics against NIAID Category A, B, or C priority agents. Diagnostic platforms/technologies may include in vivo imaging methods and development of contrast reagents for visualization of pathogens or host immune responses in vivo.
MORRIS K. UDALL CENTERS OF EXCELLENCE FOR PARKINSON'S DISEASE RESEARCH (P50) (NS-11-004)(NINDS)
Letter of intent: April 10, 2011 (Letters of intent are not mandatory)
Application due date: May 10, 2011
The National Institute of Neurological Disorders and Stroke (NINDS) invites new and renewal applications for the Morris K. Udall Centers of Excellence for Parkinson's Disease Research program. The overarching goal of the specialized Udall Centers program is to establish a network of Centers that work independently as well as collaboratively to define the causes of and discover a cure for Parkinson's disease (PD). Investigator may include development of minimally invasive diagnostic techniques, including diffusion tensor and molecular imaging techniques.
COMPLEX TECHNOLOGIES AND THERAPEUTICS DEVELOPMENT FOR MENTAL HEALTH RESEARCH AND PRACTICE (R43/R44) (NIMH) (PA-11-133)
Application dates: standard dates apply
The overarching goal of the SBIR program at the National Institute of Mental Health (NIMH) is to support small businesses to develop technologies that can advance the mission of the Institute, including in basic neuroscience research relevant to mental disorders, translational and clinical research of mental disorders, clinical diagnosis or treatment of mental disorders, and dissemination of evidence-based mental health care. Specific areas of research interest include biomarkers and biosignatures of mental illness, and development of PET and SPECT ligands for brain imaging.
INTERNATIONAL NEUROSCIENCE FELLOWSHIP (F05) (MULTIPLE ICS, NOT INCLUDING NCI) (PAR-11-106)
Letter of Intent Due Date: July 16, 2011, 2012
Application Receipt/Submission Date(s): August 16, 2011, 2012
The goal of the International Neuroscience Fellowship (INF) is to advance the training of qualified foreign neuroscientists and clinicians at the early or mid-career level, by enhancing their basic, translational or clinical research skills in a research setting in the U.S.
COMPETING RENEWAL AWARDS OF SBIR PHASE IIB GRANTS FOR BRAIN AND BEHAVIOR TOOLS (R44) (NIMH, NIA, NIAAA, NIDDK, NINDS, NCCAM) (PA-11-135)
Application dates: standard dates apply
The NIH Blueprint for Neuroscience Research is a framework to enhance cooperative activities among the NIH Office of the Director and1 5 NIH Institutes and Centers that support research on the nervous system.
DEVELOPMENT AND TRANSLATION OF MEDICAL TECHNOLOGIES TO REDUCE HEALTH DISPARITIES (R43/R44) (SBIR/STTR) (NIBIB, NCRR, NIAMS, NIMHD) (EB-11-001)
Letter of intent due dates: April 20, 2011; August 22, 2011
Application due dates: May 20, 2011; September 22, 2011
This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop and translate medical technologies aimed at reducing disparities in healthcare access and health outcomes. Appropriate medical technologies should be effective, affordable, culturally acceptable, and deliverable to those who need them. This announcement supports applications to develop medical devices, imaging systems, and other technologies that adequately address the healthcare needs of health disparity populations.
Other Funding Agencies
ANNOUNCING THE TRANSITION OF SINGLE RESEARCH PROJECT COOPERATIVE AGREEMENTS (SINGLE PROJECT U01S) TO ELECTRONIC SUBMISSION FOR DUE DATES ON OR AFTER MAY 25, 2011 (NOT-OD-11-048)
National Institutes of Health
NOTICE OF UPDATE FOR PAR-10-141, TRANSFORMING BIOMEDICINE AT THE INTERFACE OF THE LIFE AND PHYSICAL SCIENCES (R01), AND PAR-10-142, NEW BIOMEDICAL FRONTIERS AT THE INTERFACE OF THE LIFE AND PHYSICAL SCIENCES (R01) (NOT-EB-11-004)
CHANGE IN TIMETABLE FOR OPPORTUNITY TO SHORTEN THE REVIEW CYCLE FOR NEW INVESTIGATOR R01 APPLICATIONS REVIEWED IN STUDY SECTIONS CONVENED BY THE CENTER FOR SCIENTIFIC REVIEW (CSR) AND NATIONAL INSTITUTE OF MENTAL HEALTH (NIMH)(NOT-OD-11-057)
EVALUATION OF UNALLOWABLE RESUBMISSION AND OVERLAPPING APPLICATIONS
NIH limits the number of times you can resubmit an application with essentially the same content and scope as an earlier application. Rules and policies published in the NIH Guide include detailed guidance about the standards and limitations used by NIH to evaluate potential duplicate and overlapping applications: NOT-OD-10-080 and NOT-OD-09-100.
CIP DCIDE PROGRAM MORPHS INTO NExT
The Cancer Imaging Program's DCIDE program for providing data to investigators for their IND filings is being absorbed by the NCI Experimental Therapeutics Program (NExT). Submissions are due quarterly, on the 15th of February, May, August and November.
GUEST AUTHOR OPPORTUNITIES IN THE NIH MICAD DATABASE
The Molecular Imaging and Contrast Agent Database (MICAD) program has been developed as a key component of the NIH Molecular Imaging Roadmap to provide freely accessible online scientific information on in vivo molecular imaging and contrast agents. To accelerate expansion of the database to include all published agents, the MICAD program has implemented a procedure for members of the imaging community to write and submit entries (chapters) as guest authors to the database. All members of the imaging community are encouraged to consider this guest author opportunities. For further information, please contact the MICAD staff at email@example.com. Individual guest authors will be provide with detailed instructions, style guidelines, and a chapter template. The name of the contributing author(s) will be acknowledged and included in the MICAD online publication.
Breast Cancer Imaging: State of the Art 2011: Diagnosis, Therapy and Beyond
April 21-22, 2011, Bethesda, Maryland
The Natcher Center, National Institutes of Health
2011 NIH Regional Seminars on Program Funding and Grants Administration: Phoenix, AZ & Ft. Lauderdale, FL (NOT-OD-10-129) and (NOT-OD-11-038)
April 27, 2011 - NIH Electronic Research Administration (eRA) computer workshops
April 28-29, 2011 - 2011 Regional Seminar on Program Funding & Grants Administration
Location: Talking Stick Resort, Scottsdale, AZ
June 22-24, 2011 - Ft. Lauderdale, FL: (Registration expected to open early 2011).
URL: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-10-129.html URL: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-11-038.html
URL for NIH Seminars: http://grants.nih.gov/grants/seminars.htm
19th ISMRM Scientific Annual Meeting & Exhibition
Montreal, Quebec, Canada - 7-13 May 2011
2011 Society of Nuclear Medicine Annual Scientific Meeting
June 4-8, 2011, San Antonio, Texas
2011 International Symposium on Ultrasonic Imaging and Tissue Characterization
June 13 - 15, 2011, Palomar Hotel, Arlington, VA
Frontiers of Biomedical Imaging Science III
June 13 - 16, 2011, Vanderbilt University, Nashville, TN
2011 International Symposium on Radiopharmaceutical Sciences
August 28 - September 2, 2011, Amsterdam, the Netherlands
2011 World Molecular Imaging Congress
September 7-10, 2011, San Diego Convention Center, San Diego, CA
The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.
If you wish to remain on the list, no action is necessary. If you wish to be added to the list, please contact Dr Barbara Croft by return e-mail (firstname.lastname@example.org).
Please include your complete mailing address, title, phone and fax numbers.
Cancer Imaging Program, Division of Cancer Treatment and Diagnosis, NCI
6130 Executive Boulevard - MSC-7412
Bethesda, MD 20892-7412
Tel: 301 496 9531Fax: 301 480 3507